相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Microtubule-Targeting Drugs: More than Antimitotics
Roma Kaul et al.
JOURNAL OF NATURAL PRODUCTS (2019)
Verteporfin exhibits anti-proliferative activity in embryonal and alveolar rhabdomyosarcoma cell lines
Luca Sanna et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
12-O-tetradecanoylphorbol-13-acetate and EZH2 inhibition: A novel approach for promoting myogenic differentiation in embryonal rhabdomyosarcoma cells
Irene Marchesi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
The role of enhancer of zeste homolog 2: From viral epigenetics to the carcinogenesis of hepatocellular carcinoma
Luca Sanna et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Novel 1,3,4-Oxadiazole Induces Anticancer Activity by Targeting NF-κB in Hepatocellular Carcinoma Cells
Chakrabhavi Dhananjaya Mohan et al.
FRONTIERS IN ONCOLOGY (2018)
Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways
Nilambra Dogra et al.
SCIENTIFIC REPORTS (2018)
Anti-Cancer Activity of Derivatives of 1,3,4-Oxadiazole
Teresa Glomb et al.
MOLECULES (2018)
Concept of histone deacetylases in cancer: Reflections on esophageal carcinogenesis and treatment
Dimitrios Schizas et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Tubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures
Wenlong Li et al.
FUTURE MEDICINAL CHEMISTRY (2017)
Bioinformatics approaches to predict target genes from transcription factor binding data
Alexandra Essebier et al.
METHODS (2017)
1,3,4-Oxadiazoles as Telomerase Inhibitor: Potential Anticancer Agents
Shalini Bajaj et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2017)
Microtubule Targeting Agents as Cancer Chemotherapeutics: An Overview of Molecular Hybrids as Stabilizing and Destabilizing Agents
Anjana Devi Tangutur et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)
Migrastatics-Anti-metastatic and Anti-invasion Drugs: Promises and Challenges
Aneta Gandalovicova et al.
TRENDS IN CANCER (2017)
Tumor lymphangiogenesis and new drug development
Lothar C. Dieterich et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Target identification and lead discovery by functional lipidomics
Andreas Koeberle
FUTURE MEDICINAL CHEMISTRY (2016)
Synthesis and Antineoplastic Evaluation of Novel Unsymmetrical 1,3,4-Oxadiazoles
Valentina Nieddu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
A Novel Resveratrol Based Tubulin Inhibitor Induces Mitotic Arrest and Activates Apoptosis in Cancer Cells
Elizabeth Thomas et al.
SCIENTIFIC REPORTS (2016)
1,3,4-Oxadiazoles: An emerging scaffold to target growth factors, enzymes and kinases as anticancer agents
Shalini Bajaj et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Edgar Perez-Herrero et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Canonical and new generation anticancer drugs also target energy metabolism
Sara Rodriguez-Enriquez et al.
ARCHIVES OF TOXICOLOGY (2014)
Bioinformatics for cancer immunotherapy target discovery
Lars Ronn Olsen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Small-molecule EGFR tyrosine kinase inhibitors for the treatment of cancer
Chieh-Chien Lee et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2014)
Benefit and Harms of New Anti-Cancer Drugs
Francisco E. Vera-Badillo et al.
CURRENT ONCOLOGY REPORTS (2013)
Regulation of tumor angiogenesis by the microtubule-binding protein CLIP-170
Xiaodong Sun et al.
PROTEIN & CELL (2013)
An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site
Yan Lu et al.
PHARMACEUTICAL RESEARCH (2012)
Mechanisms of Drug Toxicity and Relevance to Pharmaceutical Development
F. Peter Guengerich
DRUG METABOLISM AND PHARMACOKINETICS (2011)
IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1δ/ε and Wnt/β-catenin independent inhibition of mitotic spindle formation
J. K. Cheong et al.
ONCOGENE (2011)
Noncovalent interactions in biochemistry
Kevin E. Riley et al.
WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE (2011)
Microtubule-binding agents: a dynamic field of cancer therapeutics
Charles Dumontet et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Microtubules and resistance to tubulin-binding agents
Maria Kavallaris
NATURE REVIEWS CANCER (2010)
Microtubule assembly, organization and dynamics in axons and dendrites
Cecilia Conde et al.
NATURE REVIEWS NEUROSCIENCE (2009)
Inhibitors of VEGF receptors-1 and -2 based on the 2-((pyridin-4-yl)ethyl)pyridine template
AS Kiselyov et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Microtubules as a target for anticancer drugs
MA Jordan et al.
NATURE REVIEWS CANCER (2004)
Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain
RBG Ravelli et al.
NATURE (2004)
New microtubule/tubulin-targeted anticancer drugs and novel chemotherapeutic strategies
L Wilson et al.
JOURNAL OF CHEMOTHERAPY (2004)
Microtubule-targeted anticancer agents and apoptosis
KN Bhalla
ONCOGENE (2003)
In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole
MH Pourgholami et al.
CANCER LETTERS (2001)
The effects of chelidonine on tubulin polymerisation, cell cycle progression and selected signal transmission pathways
A Panzer et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2001)
分享论文
